Fourteen participants experienced serious adverse events during the trial, including two in the placebo group, but for most participants, side-effects were mild to moderate and eased with time, with gastrointestinal symptoms the most commonly experienced
A simple GLP-1 progress tracker makes it easier to spot meaningful patterns
GLP-1 receptor agonist drugs (called GLP-1s for short) like semaglutide work by mimicking this hormone, increasing insulin release (which helps control diabetes), signaling your brain that you're full, and slowing digestion
Secretory processes, carbohydrate and lipid metabolism in isolated mouse hepatocytes: aspects of regulation by glucagon and insulin
The goal is the right treatment for your biology, not the newest one
PMID 24843404